A detailed history of Klein Pavlis & Peasley Financial, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Klein Pavlis & Peasley Financial, Inc. holds 1,895 shares of MRK stock, worth $185,804. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,895
Previous 1,716 10.43%
Holding current value
$185,804
Previous $212 Million 1.3%
% of portfolio
0.17%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$111.15 - $128.97 $19,895 - $23,085
179 Added 10.43%
1,895 $215 Million
Q2 2024

Jul 26, 2024

BUY
$123.8 - $132.96 $17,084 - $18,348
138 Added 8.75%
1,716 $212 Million
Q1 2024

May 07, 2024

BUY
$113.24 - $131.95 $178,692 - $208,217
1,578 New
1,578 $208 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Klein Pavlis & Peasley Financial, Inc. Portfolio

Follow Klein Pavlis & Peasley Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klein Pavlis & Peasley Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klein Pavlis & Peasley Financial, Inc. with notifications on news.